News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good point. I indicated he left Sintx after armor division was brought online Q1 last year but failed to add that he remains on in a consulting capacity...but you already knew that. Ill have to add that tomorrow.
Previously I indicated that when Mr Bray left Sintx, him staying on in a consulting capacity is a clue that Mr Bray was brought onboard with the main goal to get Sintx ready to supply armor and aerospace products (for Morgan Ceramics and NP Aerospace, etc..). He completed those objectives last year so its not surprising he left the company as an employee but stayed on as a consultant in case any problems arose or they needed help with regulatory filings pertaining to these divisions.
We regret to report that Don Bray has decided to leave SINTX to embark on new ventures and explore fresh opportunities. Don will continue to support SINTX in a consulting role. We want to thank Don for his service. Don’s efforts to increase awareness of SINTX in the ceramics industry and to develop a wide range of opportunities for us have led to significant customers as well as to our entry into the opaque armor market.
Mr Bray worked for Morgan Ceramics while it was working on using Sintx Si3N4 formulation for aerospace applications. He turned consultant in 2018 and for some odd reason joins SiNTx this year. His job is to establish joint agreements and one of sintx partners is his former employer. Theres a lot of ways to go with this. However the simplest explanation is that Mr. Bray's employment, his years of service at Morgan, coupled with press release mentioning aerospace, suggest Mr. Bray will handle negotiations with Morgan. Who better to handle such negotiations than a man intimately familar with the company being negotiated with?
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
You have already reached the 3 post per day limit placed on you for this board.
The limitation is until further notice.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Pretty sure he is not for buying here 
Morgan Ceramics & NP Aerospace spin-off
2016 (earlier?), Sintx began a Ceramic-Metal Brazing project in a joint effort with later disclosed Morgan Advanced Ceramics. Sintx would use the tech for spine/knee and Morgan would use the tech created for aerospace applications. Incidentally, the recent PR disclosure announcing the supply of aerospace components could be a deal to supply Morgan Technical Ceramics. If Morgan is not the "world leader in aerospace systems" mentioned in this PR, then i'd expect another announcement of such a supply deal to Morgan Ceramics. More than likely this supply deal is to Morgan Ceramics which is curiously not disclosed despite the previously disclosed collaberation with Morgan Ceramics back in 2017.
“We are excited to serve our customer who is a world leader in aerospace systems,” said Dave O’Brien, Executive Vice President and Chief Operating Officer for SINTX.
A metal-ceramic brazing project with a global ceramics manufacturer is underway, targeting the total knee market, and composite devices in the spine market.
Enter a JDA with Morgan Ceramics
Current partnerships
Morgan Advanced Ceramics
Develop a spine device utilizing Morgan's advanced joining technologies
Developing spine & knee implant with Morgan Ceramics. This would braze Si3N4 & unknown metal together, something Morgan specializes in. Morgan is also attempting to utilize this same technique for aerospace market. If successful Morgan would commercialize and sell to entitties like NASA. No signed JDA we are aware of.
After months of financial, legal and company due diligence, we finalised the deal towards midnight on November 20th
SINTX Technologies, Inc. (NASDAQ: SINT) announced today that it has hired Donald J. Bray as Vice President of Business Development. Mr. Bray was formerly Vice President of Technology at Morgan Advanced Materials, where he focused on leading strategic initiatives into new market areas. Mr. Bray will assume the new role at SINTX on 22 April 2019.
Business Director, Armor Jan 2008 - Sep 2014 6 yrs 9 mos
NP Aerospace, the world’s most advanced, composite armor company, has incorporated in the United States to provide advanced, composite tactical and combat-armored systems for vehicles and personal protection systems specifically for the U.S. military.
I forgot to add this important quote that NP Aerospace is eying strategic acquisitions in key markets, with the US being their biggest focus. One thing thats very interesting is the posters here will not discuss NP Aerospace indicating they know more about the relationship than they are allowed to let on or are somehow bound by any non-disclosures in place. Talk about evidence of a conspiracy.
The expansions we are forecasted to see in 2022 are likely to open up some opportunities for us in the long term, to do some really strategic acquisitions in key markets, which in turn will act as a catalyst for faster growth in certain regions. That potential is certainly there for us in the US, which is very exciting,” James concludes.
You have already reached the 3 post per day limit placed on you for this board.
The limitation is until further notice.
Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'.
One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
The problem with that is it doesnt account for the fact that Sonny didnt become CEO based solely on his own merit but in large part due to his ties to Zimmer. Also the idea of him fleecing shareholders is incorrect. If the goal was, from the moment the 2013 IPO paperwork was filed, to go private again, Sonnys goal upon taking over Sintx would not be to "fleece" individuals but utilize public markets to raise funds to fund R&D. Its the hfudges that would be fleecing shareholders as they have to move their shares. That said, if the goal was to go private from the onset (before Sonny was even CEO), then he would want to see Sintx valuation stay low. If going private is the goal id keep an eye out for an acquisition offer from NP Aerospace. An alternative to that is a reverse merger so NP could go public. Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Sonny is doing things by himself? CTL handles spine sales, NP Aerospace would handle armor sales, Zimmer Biomet would handle at least Hip & Knee sales. They supply aerospace components to unspecified aerospace companies. The only product he attempted to commercialize as an OEM and failed to, is the masks. That said, masks are free to commercialize with another company. Not a stretch to imagine that Zimmer Biomet could sell masks. I mean the company is looking to diversify its revenue sources.
Sintx-Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx-Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
Zimmer Biomet pays $2.5m certain R&D payment Q2 2017, Dr Bal's investment fund loans $2.5m to Sintx Q3, 2017
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174152867
========================================
Mictrade you do not seem capable of posting anything but disinformation posts.
https://www.ethosdebate.com/lies-rhetoric-4-18-rules-disinformation/
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
In 2017 the results of testing of Sintx femoral head coupled against Zimmer Biomets (originally Biomet IP) E1 liner was announced. Within the press release it was disclosed that Sintx and Zimmer Biomet both donated IP for testing but that neither company sponsored the testing. Consulting for testing was provided by Sintx scientific advisor Dr Pezzotti, amoung others, who has also done extensive testing for Biomet on its liners like E1 & Arcom products. Thus he is intimately familiar with both companies IP. See my post on Dr Pezzotti's Biomet related research. It is for this reason, and others, i have said that Zimmer Biomet is a stakeholder in Sintx. It had interest in the results of this testing. The fact that before this, in 2007, the results of co-sponsored testing involving Sintx femoral head and Biomets liner only further validates the statement. That coupled with the fact that Dr. Pezzotti does work for both companies.
This independent wear study was conducted in accordance with international standards at the Medical Technology Laboratory of the Rizzoli Orthopaedic Institute (Bologna, Italy) by Professor Aldo Toni MD under the supervision of Dr. Saverio Affatato PhD (Rizzoli Institute) with consultation and support from Professor Giuseppe Pezzotti PhD (Ceramic Physics Laboratory, Kyoto Institute of Technology, Sakyo-ku, Kyoto Japan). Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research.
Certain R&D agreements relate to agreements with upfront payments to obtain intellectual property to be used in R&D projects that have no alternative future use in other projects.
On July 28, 2017, Amedica Corporation (“Amedica” or the “Company”) closed on a $2.5 million term loan (the Loan”) with North Stadium Investments, LLC (“North Stadium”), a company owned and controlled by the Company’s Chief Executive Officer and Chairman of the Board, Dr. Sonny Bal. In connection with the Loan, the Company issued to North Stadium, a Secured Promissory Note in the amount of $2.5 million (the “Note”). The Note bears interest at the rate of 10% per annum, requires the Company to make monthly interest only payments for a period of 12 months, and principal and any unpaid accrued interest are due and payable 12 months from the effective date of the Note, July 28, 2017. The Note is secured by substantially all of the assets of the Company pursuant to a security agreement between the Company and North Stadium dated July 28, 2017 (the “Security Agreement”), and is junior to the already existing security interest in such assets of the Company held by Hercules Capital, Inc. In connection with the Loan and as additional consideration for the Loan, the Company issued to North Stadium a warrant to acquire up to 660,000 common shares with a purchase price set at $0.42 per share and a 5 year term (the “Warrant”).
All those companies youre referencing almost always are riddled with debt, an important detail youre omitting . Thats usually where scamming comes into play. The companies debtors are the ones that are playing the stockmarket and investors to make back as much of the debt as they can before the company goes bankrupt or creditors possibly buy the company take it private. Thats exactly what happened with Pernix although i have no idea what happened to the IP after its BK. Once the debt is shed then suddenly those companies can succeed. Thats not the case with Sintx as there are no real debtors/debt. Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Sintx is still a public company so if Sintx going puiblic was a giant con to fund R&D and go private again, then the scam isnt complete and theres still time to stop it. The only con going on atm, is the one being used to scare investors away through continued naked shorting of offerings to drive the price lower combined with constant posts on forums the company is a scam. Again, there has been nothing to justify the drop in stockprice since late 2022 other than that. If Sintx was properly valued then this wouldnt be an issue. The con is that Sintx isnt worth investing in whether management is part of this or not. The goal seems to be to create the context to acquire Sintx, or its IP, cheap and then make a boat ton private when deals suddenly appear. The fact that management purposefully did not disclose and removed the fact that Dr Bal and Dr Link were connected to Zimmer in the companies IPO paperwork is a redflag that they could be part of keeping Sintx from being successful publicly. Those facts were very much there when Sintx tried to IPO for a proper valuation ($225m if memory services) in 2007. 225m valuation when it had only 3 product candidates. Now so many more exist.
Sintx-Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Management Ties to Zimmer omitted from the 2013 IPO paperwork
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174144294
Sintx-Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
A company that goes public just to fund R&D and then go private again shouldn't be classified as a scam. There should be a different name for it. Its definitely a con job but not a scam because the company and products are legit, just not the intentions. Dont kid yourself though, if this is the intention youre a participant in it. Youre helping it by making sure Sintx goes private and for cheap. To fight it would be to see the stock goes up in price not help it go down. The IP remains worth $225+m which was what Sintx tried to go public for in 2007 when it included the information that certain officers were tied to Zimmer before it sold a product on market. As ive indicated, for Sintx to go private will only delay development. Back in 2007 Sintx had spinal implant candidate and a hip implant it was working on with Biomet with Sonny aiding. Now Sintx has far more product candidates in addition to those. Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Sintx-Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx-Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Leaving it from the information about Sonny could be an oversight but the summary about Dr Link was purposefully changed to remove Zimmer and downplay Centerpulse's significance.
the only thing it would prove imo, is that Sint was never a good investment to begin with.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Joe what's your opinion on the information about Zimmer being excluded in the 2013 IPO paperwork?
If warning people was the only goal, there would be no need for disinformation and untrue information to be posted.
@syfa Precisely WHY WOULD $SINT - a Co with one 10ye contract of like $80k a year and spine sales that generate Negative Gross Profit and No other sales be worth $60mil ????
Valued at potentially as much as $8 million over the life of the agreement, the LTA represents the single largest customer agreement to date for SINTX.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Theres definitely a concerted effort here to scare every investor away. The only reason to do that is to steal this tech without worry of lawsuits and investigations. Sonny could be involved in this if the goal is to take Sintx private again super cheap, then sell to Zimmer Biomet in some form later. That is an unfortunate thing to consider. I hope instead that Sintx is and has been under attack by outside forces instead of the idea its been inside ones. With the amount of effort Sonny has used to protect IP, the only option left maybe to bankrupt Sintx to get the tech. Right now it looks like Sonny is doing a last ditch effort to raise funds before Sintx is delisted.
The better position Sintx is in the more aggressive the market manipulation has been. An investigation needs to occur. The tech is too important. Every offering is naked shorted and this is easily confirmed in the SECs fail to deliver data. Millions upon millions have been failed to deliver in regards to Sintx this year. This doesnt represent the total of shares naked shorted just what wasnt covered in a timely fashion.
20240201|829392604|SINT|696466|SINTX TECHNOLOGIES INC COM COM|0.15
20240202|829392604|SINT|5939951|SINTX TECHNOLOGIES INC COM COM|0.15
20240205|829392604|SINT|113856|SINTX TECHNOLOGIES INC COM COM|0.16
20240223|829392604|SINT|331948|SINTX TECHNOLOGIES INC COM COM|0.14
https://www.sec.gov/data/foiadocsfailsdatahtm
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
One would hope SEC was watching. This is sooooo undervalued due to abusive naked shorting which causes more shares to be released per offering and more offerings due to the fact they are unable to raise much per offering.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
I forgot to add the fact that Zimmer Biomet hired a Si3N4 coatings expert Mr Bond, they have a saying in Chicago: 'Once is happenstance. Twice is coincidence. The third time it's enemy action'. One is an incident, two is a coincidence, three's a pattern, and four is enough for a warrant
Sintx-Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx-Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Zimmer Biomet Hires Si3N4 Coatings Expert
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174115529
========================================
In other news it seems that an area in upper China suffered 50 degree Celsius drop, which equates to a 122 Fahrenheit, over two day period freezing birds into a lake and freezing the lake extremely fast. This is the sort of thing youd see in the movie 'Day After Tomorrow'. The blanket term climate change cannot account for this, but the work of Dr Solis actually can explain why the earth is both heating and cooling at the same time. Simply put, the earths magnetic field is weakening allowing more radiation into the earths atmosphere heating things up. Yep we arent the cause. At the same time, the magnetic field is becoming more chaotic causing bands of the field to shoot outward into space like a sunspot. As the band shoots out into space the plasma in the upper atmosphere goes with it causing the plasma to loose energy into space effectively cooling it. This is why the upper atmosphere is cooling. The 'Day After Tomorrow' movie essentially depicts this extreme coldness working its way down to the earths surface from the upper atmosphere in an extremely accelerated manner than what would transpire in reality. The mechanism depicted however is real and what happened in China appears to be a real example of it.
What is the problem of this happening in regards to Sintx? Well a weakening magnetic field means that patients with metal implants will be exposed to greater amounts of radiation. That will cause increase in disease, corrosion, and likely spontaneous fracturing of the implants because metal implants amplify and "collect" this incoming radiation. Thus the ortho industry needs to shift to ceramics to address this growing problem. The best and safest ceramic im aware of atm is Sintx Si3N4.
This increasing radiation exposure is also causing building collapses due to the Hutchison Effect and thus the building industry needs to also switch to ceramics somehow. A company in California is developing 500 year ceramic dome buildings.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im not saying the world should stop but instead should not be heading in the direction its going. We should use technology to reduce our dependence on it not increase it. Leaders should be more honest with whats really going on instead of employing so much deception and creating so much division. The worlds general direction seems to be greater dependence on tech. I suspect that leaders are trying to address the problems using technology, which is the wrong way to go about this and will have unforeseen consequences like what happened with Ms Chao.
My presence here for all these years has nothing to do with me not accepting that things do not happen on my terms, understanding, or timing. This isnt about me. In fact my presence here is part of something bigger. Yes, it is frustrating things are taking as long as they are to play out but im not repeating myself because of that but rather to establish consistency; again this is part of a bigger picture. I also do not fall in line or follow the leader unless i believe in that leader. I can tell you ive seen no leaders worth following.
One of the reasons im here is to encourage quicker development of Si3N4 for the greater good and expose some of the corruption with the markets. For instance if whats happening with Sintx stock has anything to do with distracting from the following connections, then thats an element of a corrupted market. Or how Tesla is a fake it until you make it scam, again element of a corrupted market. These represent two different cons, one to falsely prop up with Tesla and one to falsely push down with SINT.
Sintx-Zimmer Connection
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053353
Sintx-Biomet R&D
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174053136
Dr. Pezzotti member of Sintx scientific board and his research for Biomet
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174052660
Tesla = Fake it until you make it scam
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174085276
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Stop looking at them individually and start looking at them in aggregate. EMI is already known to cause all the problems in the various incidents i point out. Its also why i can predict these events before they happen. The point of the ship, the plane, Tesla, all the other events that i predicted would happen all happened along with a giant CME and severe geostorm which takes days to fully dissipate. How many times must this happen for you to consider that its not simply correlation?
Looks like a significant CME, maybe more than 1, is heading our way so could see some out of control Teslas, some spontaneously combusting, and some battery storage fires which tend to happen most around spring/fall equinoxes. Watch for plane crashes, pipeline/refinery fires, building/bridge collapses, train derailments, and even earthquakes.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
I do not know why, but there does not seem to be studies connecting immune responses/disease connected to the combination of EMFs like indicated in this first study and the next article listing immune disorders associated with metal implants. In reality its likely that metal ions/metal implants themselves coupled with natural/man-made EMF sources that causing worsening autoimmune issues. You do not necessarily need to have metal implants to worsen this problem. For instance, multi-vitamins could worsen this by aiding in increasing magnetic metals, which are necessary in small quantities, in the body. Thus the only solution to this problem is to switch to ceramics and plastics in the greater Ortho-Dental market. Currently there is only one ceramic material that could replace metal components, or coat them to reduce ion release, and that material is Sintx Si3N4. However to accomplish this Sintx must successfully develop methods of 3D printing to address Si3N4's one major drawback, its modulus of elasticity. A collaboration with 3DCeram Sinto began last year for just this purpose. A number of papers dealing with the effects of modern, man-made electromagnetic fields (EMFs) on the immune system are summarized in the present review. EMFs disturb immune function through stimulation of various allergic and inflammatory responses, as well as effects on tissue repair processes. Such disturbances increase the risks for various diseases, including cancer. These and the EMF effects on other biological processes (e.g. DNA damage, neurological effects, etc.) are now widely reported to occur at exposure levels significantly below most current national and international safety limits. Obviously, biologically based exposure standards are needed to prevent disruption of normal body processes and potential adverse health effects of chronic exposure.
Disturbance of the immune system by electromagnetic fields—A potentially underlying cause for cellular damage and tissue repair reduction which could lead to disease and impairment
Autoimmune diseases associated with metal in medical and dental implants and devices
While numerous health conditions have been related to the presence of metals in the body, scientific research has clearly shown that autoimmune disease can be associated with metals used in dentistry and medicine, including metals in medical and dental implants, devices, and adjuvants (substances added to vaccines such as aluminum and mercury). Several of the autoimmune diseases studied for their relation to metal in medical and dental implants, devices, and adjuvants include the following:
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im sure by now you all have read about the ship that went all Maximum Overdrive into a bridge? Think its a coincidence that happened after the Obamas depicted this in "Leave the World Behind" and a major Geomagnetic storm occurred? Have i not been telling you all for years this sort of thing was going to happen and more frequently? Keep watching! More people are going to be become sicker due to their metal implants during such storms, increased radiation exposure due to a weakening magnetic field, and increasing exposure to man-made radiation sources like wifi, 5G, & EVs..
BALTIMORE (Reuters) -A massive cargo ship crippled by a loss of power smashed into a bridge while sailing out of Baltimore Harbor early on Tuesday, sending vehicles and people into the river below and closing one of the busiest ports on the U.S. Eastern Seaboard.
Certain of our outstanding shares of convertible preferred stock and warrants contain full-ratchet anti-dilution protection, which may cause significant dilution to our stockholders.
We currently have outstanding 26 shares of Series B convertible preferred stock convertible into an aggregate of 114,400 shares of Common Stock, and warrants issued in October 2022 that are exercisable for an aggregate of 616,641 shares of Common Stock. The Series B convertible preferred stock and October 2022 warrants contain full-ratchet anti-dilution provisions which, subject to limited exceptions, would reduce the conversion price of the Series B preferred stock (and increase the number of shares issuable under the Series B preferred stock) and reduce the exercise price of the October 2022 warrants in the event that we in the future issue Common Stock, or securities convertible into or exercisable to purchase Common Stock, at a price per share lower than the conversion price or exercise price then in effect. Depending upon how such provisions are interpreted, the alternative cashless exercise provision contained in the Class C Warrants and Class D Warrants could potentially result in a significant reduction in the conversion or exercise price of the Series B convertible preferred stock and October 2022 warrants. Our outstanding 26 shares of Series B preferred stock are, prior to this offering, convertible into 114,400 shares of Common Stock at a conversion price of $0.25 per share. The October 2022 warrants are exercisable at an exercise price of $0.25 per share. These full ratchet anti-dilution provisions will likely be triggered by the issuance of the Units in this offering.
Investors participating in the February 2010 closing that purchased at least 12,500 shares of our Series E convertible preferred stock had the right to convert, on a one-for-one basis, shares of our previously issued Series A convertible preferred stock, Series B convertible preferred stock, Series C convertible preferred stock and Series D convertible preferred stock already owned by the investor into a corresponding new series of our convertible preferred stock with a more favorable conversion rate. Directors, officers and beneficial owners of more than 5% of our common stock, on an as converted basis, and their affiliates participated in this conversion right as follows:
SEVERE GEOMAGNETIC STORM--THE STRONGEST IN YEARS: As predicted, a CME struck Earth's magnetic field on March 24th (1437 UT). The impact opened a crack in our planet's magnetosphere and sparked a severe G4-class geomagnetic storm--the strongest geomagnetic storm since Sept. 2017.
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
|
Followers
|
241
|
Posters
|
|
|
Posts (Today)
|
10
|
Posts (Total)
|
41903
|
|
Created
|
02/13/14
|
Type
|
Free
|
| Moderators | |||
https://www.youtube.com/watch?v=j94SgeyCh3M
(AMDA) Amedica Corp. - NASDAQ
 |   |
RECENT NEWS
https://www.youtube.com/watch?v=hxbj7Sq7W94
https://www.youtube.com/watch?v=j94SgeyCh3M
https://www.youtube.com/watch?v=KbU47COpXx8
AI
